On September 18, JD HEALTH rose 3.05% in regular trading, trading at HK$35.76/share, with turnover of approximately HK$105 million. The rally was driven by a flurry of AI+healthcare initiatives from the company in recent days.

On September 10, JD HEALTH unveiled version 3.0 of its proprietary medical large language model and announced a strategic upgrade in AI+medical devices, with the number of AI-integrated products doubling compared to mid-year levels. On September 11, the company showcased its full-scenario AI+ applications and integrated healthcare service loop at the China International Fair for Trade in Services, demonstrating end-to-end capabilities spanning consultation, testing, diagnosis, and medication.

The broader sector traded positively, with BABA-W up 4.19%, ALI HEALTH up 1.19%, and PA GOODDOCTOR up 1.0%. JD HEALTH reported total revenue of RMB 73.4 billion for the prior fiscal year, up 26.3% year-over-year, with annual active users reaching 218 million. The company also completed a share buyback of approximately 21.54 million shares for around HK$839 million, which were subsequently cancelled in July.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)